首页> Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association> Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.

Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： João Pedro,Ferreira

第一单位： Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, UMR, CHRU de Nancy, Nancy, France.;F-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France, Nancy.;Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.

作者： João Pedro,Ferreira ^[1] ; Cécile,Couchoud ^[2] ; John,Gregson ^[3] ; Aurélien,Tiple ^[4] ; François,Glowacki ^[5] ; Gerard,London ^[6] ; Rajiv,Agarwal ^[7] ; Patrick,Rossignol ^[8]

作者单位： Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, UMR, CHRU de Nancy, Nancy, France.;F-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France, Nancy.;Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal. ^[1] Agence de la biomédecine, Avenue du Stade-de-France, Saint-Denis-La-Plaine Cedex, France. ^[2] London School of Hygiene and Tropical Medicine, London, UK. ^[3] Service de Néphrologie, CHRU de Clermont-Ferrand, Clermont-Ferrand, France. ^[4] EA 4483-IMPECS-IMPact of Environmental Chemicals on Human Health, Faculté de Médecine/Pôle Recherche, Univ. Lille, place de Verdun, Lille Cedex, France. ^[5] F-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France, Nancy.;Department of Nephrology, Hospital Manhes, Fleury-Mérogis, France and. ^[6] Department of Medicine, Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA. ^[7] Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, UMR, CHRU de Nancy, Nancy, France.;F-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France, Nancy. ^[8]

关键词 end-stage renal disease mortality neurohormonal blocking agents